nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—breast cancer	0.737	1	CbGaD
Terbutaline—BCHE—Irinotecan—breast cancer	0.0239	1	CbGbCtD
Terbutaline—Bambuterol—BCHE—breast cancer	0.00179	0.394	CrCbGaD
Terbutaline—Clenbuterol—TNF—breast cancer	0.000858	0.189	CrCbGaD
Terbutaline—Clenbuterol—CYP1A1—breast cancer	0.000652	0.143	CrCbGaD
Terbutaline—Flushing—Irinotecan—breast cancer	0.000474	0.00247	CcSEcCtD
Terbutaline—Rash—Anastrozole—breast cancer	0.000474	0.00247	CcSEcCtD
Terbutaline—Rash—Letrozole—breast cancer	0.000474	0.00247	CcSEcCtD
Terbutaline—Dermatitis—Letrozole—breast cancer	0.000473	0.00246	CcSEcCtD
Terbutaline—Dermatitis—Anastrozole—breast cancer	0.000473	0.00246	CcSEcCtD
Terbutaline—Dizziness—Raloxifene—breast cancer	0.000471	0.00245	CcSEcCtD
Terbutaline—Headache—Anastrozole—breast cancer	0.000471	0.00245	CcSEcCtD
Terbutaline—Headache—Letrozole—breast cancer	0.000471	0.00245	CcSEcCtD
Terbutaline—Insomnia—Tamoxifen—breast cancer	0.000465	0.00242	CcSEcCtD
Terbutaline—Paraesthesia—Tamoxifen—breast cancer	0.000462	0.0024	CcSEcCtD
Terbutaline—Cramp muscle—Docetaxel—breast cancer	0.000459	0.00239	CcSEcCtD
Terbutaline—Chest pain—Vinorelbine—breast cancer	0.000459	0.00239	CcSEcCtD
Terbutaline—Dyspnoea—Tamoxifen—breast cancer	0.000458	0.00239	CcSEcCtD
Terbutaline—Vomiting—Idarubicin—breast cancer	0.000453	0.00236	CcSEcCtD
Terbutaline—Vomiting—Raloxifene—breast cancer	0.000453	0.00236	CcSEcCtD
Terbutaline—Paraesthesia—Melphalan—breast cancer	0.000452	0.00235	CcSEcCtD
Terbutaline—Rash—Raloxifene—breast cancer	0.000449	0.00234	CcSEcCtD
Terbutaline—Rash—Idarubicin—breast cancer	0.000449	0.00234	CcSEcCtD
Terbutaline—Dermatitis—Raloxifene—breast cancer	0.000449	0.00234	CcSEcCtD
Terbutaline—Dermatitis—Idarubicin—breast cancer	0.000449	0.00234	CcSEcCtD
Terbutaline—Dyspnoea—Melphalan—breast cancer	0.000449	0.00234	CcSEcCtD
Terbutaline—Headache—Idarubicin—breast cancer	0.000447	0.00232	CcSEcCtD
Terbutaline—Headache—Raloxifene—breast cancer	0.000447	0.00232	CcSEcCtD
Terbutaline—Nausea—Letrozole—breast cancer	0.000446	0.00232	CcSEcCtD
Terbutaline—Nausea—Anastrozole—breast cancer	0.000446	0.00232	CcSEcCtD
Terbutaline—Insomnia—Goserelin—breast cancer	0.000444	0.00231	CcSEcCtD
Terbutaline—Paraesthesia—Goserelin—breast cancer	0.000441	0.00229	CcSEcCtD
Terbutaline—Dyspnoea—Goserelin—breast cancer	0.000438	0.00228	CcSEcCtD
Terbutaline—Anxiety—Thiotepa—breast cancer	0.000437	0.00227	CcSEcCtD
Terbutaline—Somnolence—Goserelin—breast cancer	0.000436	0.00227	CcSEcCtD
Terbutaline—Tachycardia—Vinorelbine—breast cancer	0.000429	0.00223	CcSEcCtD
Terbutaline—Muscle spasms—Irinotecan—breast cancer	0.000427	0.00222	CcSEcCtD
Terbutaline—Nausea—Raloxifene—breast cancer	0.000423	0.0022	CcSEcCtD
Terbutaline—Nausea—Idarubicin—breast cancer	0.000423	0.0022	CcSEcCtD
Terbutaline—Hypertonia—Epirubicin—breast cancer	0.000415	0.00216	CcSEcCtD
Terbutaline—Asthenia—Chlorambucil—breast cancer	0.000414	0.00216	CcSEcCtD
Terbutaline—Tachycardia—Thiotepa—breast cancer	0.00041	0.00213	CcSEcCtD
Terbutaline—Paraesthesia—Vinorelbine—breast cancer	0.000395	0.00206	CcSEcCtD
Terbutaline—Dyspnoea—Vinorelbine—breast cancer	0.000392	0.00204	CcSEcCtD
Terbutaline—Salbutamol—CYP3A4—breast cancer	0.000387	0.0851	CrCbGaD
Terbutaline—Flushing—Paclitaxel—breast cancer	0.000386	0.00201	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—breast cancer	0.000384	0.002	CcSEcCtD
Terbutaline—Asthenia—Vinblastine—breast cancer	0.00038	0.00198	CcSEcCtD
Terbutaline—Chest pain—Mitoxantrone—breast cancer	0.000378	0.00197	CcSEcCtD
Terbutaline—Paraesthesia—Thiotepa—breast cancer	0.000377	0.00196	CcSEcCtD
Terbutaline—Anxiety—Mitoxantrone—breast cancer	0.000377	0.00196	CcSEcCtD
Terbutaline—Somnolence—Thiotepa—breast cancer	0.000373	0.00194	CcSEcCtD
Terbutaline—Asthenia—Tamoxifen—breast cancer	0.000369	0.00192	CcSEcCtD
Terbutaline—Chest pain—Gemcitabine—breast cancer	0.000368	0.00192	CcSEcCtD
Terbutaline—Vomiting—Chlorambucil—breast cancer	0.000367	0.00191	CcSEcCtD
Terbutaline—Chest pain—Fluorouracil—breast cancer	0.000362	0.00189	CcSEcCtD
Terbutaline—Asthenia—Melphalan—breast cancer	0.000361	0.00188	CcSEcCtD
Terbutaline—Epinephrine—TNF—breast cancer	0.00036	0.0792	CrCbGaD
Terbutaline—Tension—Paclitaxel—breast cancer	0.000356	0.00185	CcSEcCtD
Terbutaline—Tachycardia—Mitoxantrone—breast cancer	0.000354	0.00184	CcSEcCtD
Terbutaline—Asthenia—Goserelin—breast cancer	0.000352	0.00183	CcSEcCtD
Terbutaline—Nervousness—Paclitaxel—breast cancer	0.000352	0.00183	CcSEcCtD
Terbutaline—Hyperhidrosis—Mitoxantrone—breast cancer	0.000351	0.00183	CcSEcCtD
Terbutaline—Hyperhidrosis—Irinotecan—breast cancer	0.000351	0.00183	CcSEcCtD
Terbutaline—Dizziness—Vinblastine—breast cancer	0.00035	0.00182	CcSEcCtD
Terbutaline—Muscle spasms—Paclitaxel—breast cancer	0.000348	0.00181	CcSEcCtD
Terbutaline—Nausea—Chlorambucil—breast cancer	0.000343	0.00179	CcSEcCtD
Terbutaline—Hyperhidrosis—Gemcitabine—breast cancer	0.000341	0.00178	CcSEcCtD
Terbutaline—Dizziness—Tamoxifen—breast cancer	0.00034	0.00177	CcSEcCtD
Terbutaline—Tremor—Paclitaxel—breast cancer	0.000339	0.00177	CcSEcCtD
Terbutaline—Tachycardia—Fluorouracil—breast cancer	0.000339	0.00176	CcSEcCtD
Terbutaline—Vomiting—Vinblastine—breast cancer	0.000336	0.00175	CcSEcCtD
Terbutaline—Headache—Vinblastine—breast cancer	0.000331	0.00173	CcSEcCtD
Terbutaline—Insomnia—Irinotecan—breast cancer	0.000328	0.00171	CcSEcCtD
Terbutaline—Flushing—Docetaxel—breast cancer	0.000327	0.0017	CcSEcCtD
Terbutaline—Vomiting—Tamoxifen—breast cancer	0.000327	0.0017	CcSEcCtD
Terbutaline—Isoprenaline—CYP1A1—breast cancer	0.000326	0.0717	CrCbGaD
Terbutaline—Paraesthesia—Mitoxantrone—breast cancer	0.000326	0.0017	CcSEcCtD
Terbutaline—Paraesthesia—Irinotecan—breast cancer	0.000326	0.0017	CcSEcCtD
Terbutaline—Dizziness—Goserelin—breast cancer	0.000325	0.00169	CcSEcCtD
Terbutaline—Rash—Tamoxifen—breast cancer	0.000324	0.00169	CcSEcCtD
Terbutaline—Dermatitis—Tamoxifen—breast cancer	0.000324	0.00169	CcSEcCtD
Terbutaline—Dyspnoea—Irinotecan—breast cancer	0.000323	0.00168	CcSEcCtD
Terbutaline—Dyspnoea—Mitoxantrone—breast cancer	0.000323	0.00168	CcSEcCtD
Terbutaline—Somnolence—Irinotecan—breast cancer	0.000322	0.00168	CcSEcCtD
Terbutaline—Somnolence—Mitoxantrone—breast cancer	0.000322	0.00168	CcSEcCtD
Terbutaline—Headache—Tamoxifen—breast cancer	0.000322	0.00168	CcSEcCtD
Terbutaline—Palpitations—Paclitaxel—breast cancer	0.00032	0.00167	CcSEcCtD
Terbutaline—Vomiting—Melphalan—breast cancer	0.00032	0.00167	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—breast cancer	0.000319	0.00166	CcSEcCtD
Terbutaline—Rash—Melphalan—breast cancer	0.000317	0.00165	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—breast cancer	0.000317	0.00165	CcSEcCtD
Terbutaline—Flushing—Capecitabine—breast cancer	0.000317	0.00165	CcSEcCtD
Terbutaline—Dermatitis—Melphalan—breast cancer	0.000317	0.00165	CcSEcCtD
Terbutaline—Asthenia—Vinorelbine—breast cancer	0.000315	0.00164	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—breast cancer	0.000315	0.00164	CcSEcCtD
Terbutaline—Nausea—Vinblastine—breast cancer	0.000314	0.00164	CcSEcCtD
Terbutaline—Insomnia—Fluorouracil—breast cancer	0.000314	0.00164	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—breast cancer	0.000314	0.00163	CcSEcCtD
Terbutaline—Vomiting—Goserelin—breast cancer	0.000312	0.00163	CcSEcCtD
Terbutaline—Paraesthesia—Fluorouracil—breast cancer	0.000312	0.00162	CcSEcCtD
Terbutaline—Dyspnoea—Fluorouracil—breast cancer	0.00031	0.00161	CcSEcCtD
Terbutaline—Rash—Goserelin—breast cancer	0.00031	0.00161	CcSEcCtD
Terbutaline—Dermatitis—Goserelin—breast cancer	0.000309	0.00161	CcSEcCtD
Terbutaline—Somnolence—Fluorouracil—breast cancer	0.000309	0.00161	CcSEcCtD
Terbutaline—Chest pain—Paclitaxel—breast cancer	0.000308	0.00161	CcSEcCtD
Terbutaline—Headache—Goserelin—breast cancer	0.000308	0.0016	CcSEcCtD
Terbutaline—Anxiety—Paclitaxel—breast cancer	0.000307	0.0016	CcSEcCtD
Terbutaline—Nausea—Tamoxifen—breast cancer	0.000305	0.00159	CcSEcCtD
Terbutaline—Dry mouth—Paclitaxel—breast cancer	0.000302	0.00157	CcSEcCtD
Terbutaline—Asthenia—Thiotepa—breast cancer	0.000301	0.00157	CcSEcCtD
Terbutaline—Nausea—Melphalan—breast cancer	0.000299	0.00156	CcSEcCtD
Terbutaline—Muscle spasms—Docetaxel—breast cancer	0.000295	0.00154	CcSEcCtD
Terbutaline—Nausea—Goserelin—breast cancer	0.000292	0.00152	CcSEcCtD
Terbutaline—Dizziness—Vinorelbine—breast cancer	0.000291	0.00151	CcSEcCtD
Terbutaline—Tachycardia—Paclitaxel—breast cancer	0.000289	0.0015	CcSEcCtD
Terbutaline—Muscle spasms—Capecitabine—breast cancer	0.000286	0.00149	CcSEcCtD
Terbutaline—Hyperhidrosis—Paclitaxel—breast cancer	0.000286	0.00149	CcSEcCtD
Terbutaline—Drowsiness—Methotrexate—breast cancer	0.000283	0.00147	CcSEcCtD
Terbutaline—Vomiting—Vinorelbine—breast cancer	0.00028	0.00146	CcSEcCtD
Terbutaline—Tremor—Capecitabine—breast cancer	0.000279	0.00145	CcSEcCtD
Terbutaline—Dizziness—Thiotepa—breast cancer	0.000278	0.00145	CcSEcCtD
Terbutaline—Rash—Vinorelbine—breast cancer	0.000277	0.00144	CcSEcCtD
Terbutaline—Dermatitis—Vinorelbine—breast cancer	0.000277	0.00144	CcSEcCtD
Terbutaline—Headache—Vinorelbine—breast cancer	0.000275	0.00143	CcSEcCtD
Terbutaline—Sweating—Methotrexate—breast cancer	0.000272	0.00141	CcSEcCtD
Terbutaline—Palpitations—Docetaxel—breast cancer	0.000271	0.00141	CcSEcCtD
Terbutaline—Insomnia—Paclitaxel—breast cancer	0.000267	0.00139	CcSEcCtD
Terbutaline—Vomiting—Thiotepa—breast cancer	0.000267	0.00139	CcSEcCtD
Terbutaline—Paraesthesia—Paclitaxel—breast cancer	0.000266	0.00138	CcSEcCtD
Terbutaline—Drowsiness—Epirubicin—breast cancer	0.000265	0.00138	CcSEcCtD
Terbutaline—Rash—Thiotepa—breast cancer	0.000265	0.00138	CcSEcCtD
Terbutaline—Dermatitis—Thiotepa—breast cancer	0.000265	0.00138	CcSEcCtD
Terbutaline—Dyspnoea—Paclitaxel—breast cancer	0.000264	0.00137	CcSEcCtD
Terbutaline—Headache—Thiotepa—breast cancer	0.000263	0.00137	CcSEcCtD
Terbutaline—Somnolence—Paclitaxel—breast cancer	0.000263	0.00137	CcSEcCtD
Terbutaline—Palpitations—Capecitabine—breast cancer	0.000263	0.00137	CcSEcCtD
Terbutaline—Chest pain—Docetaxel—breast cancer	0.000261	0.00136	CcSEcCtD
Terbutaline—Nausea—Vinorelbine—breast cancer	0.000261	0.00136	CcSEcCtD
Terbutaline—Asthenia—Irinotecan—breast cancer	0.00026	0.00135	CcSEcCtD
Terbutaline—Asthenia—Mitoxantrone—breast cancer	0.00026	0.00135	CcSEcCtD
Terbutaline—Dry mouth—Docetaxel—breast cancer	0.000256	0.00133	CcSEcCtD
Terbutaline—Sweating—Epirubicin—breast cancer	0.000254	0.00132	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—breast cancer	0.000253	0.00132	CcSEcCtD
Terbutaline—Chest pain—Capecitabine—breast cancer	0.000253	0.00132	CcSEcCtD
Terbutaline—Anxiety—Capecitabine—breast cancer	0.000252	0.00131	CcSEcCtD
Terbutaline—Nausea—Thiotepa—breast cancer	0.000249	0.0013	CcSEcCtD
Terbutaline—Dry mouth—Capecitabine—breast cancer	0.000248	0.00129	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—breast cancer	0.000245	0.00128	CcSEcCtD
Terbutaline—Tachycardia—Docetaxel—breast cancer	0.000245	0.00127	CcSEcCtD
Terbutaline—Dizziness—Irinotecan—breast cancer	0.00024	0.00125	CcSEcCtD
Terbutaline—Tachycardia—Capecitabine—breast cancer	0.000237	0.00123	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—breast cancer	0.000235	0.00122	CcSEcCtD
Terbutaline—Hyperhidrosis—Capecitabine—breast cancer	0.000235	0.00122	CcSEcCtD
Terbutaline—Vomiting—Mitoxantrone—breast cancer	0.000231	0.0012	CcSEcCtD
Terbutaline—Vomiting—Irinotecan—breast cancer	0.000231	0.0012	CcSEcCtD
Terbutaline—Dizziness—Fluorouracil—breast cancer	0.00023	0.0012	CcSEcCtD
Terbutaline—Rash—Irinotecan—breast cancer	0.000229	0.00119	CcSEcCtD
Terbutaline—Rash—Mitoxantrone—breast cancer	0.000229	0.00119	CcSEcCtD
Terbutaline—Dermatitis—Mitoxantrone—breast cancer	0.000228	0.00119	CcSEcCtD
Terbutaline—Dermatitis—Irinotecan—breast cancer	0.000228	0.00119	CcSEcCtD
Terbutaline—Headache—Irinotecan—breast cancer	0.000227	0.00118	CcSEcCtD
Terbutaline—Headache—Mitoxantrone—breast cancer	0.000227	0.00118	CcSEcCtD
Terbutaline—Insomnia—Docetaxel—breast cancer	0.000227	0.00118	CcSEcCtD
Terbutaline—Paraesthesia—Docetaxel—breast cancer	0.000225	0.00117	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—breast cancer	0.000225	0.00117	CcSEcCtD
Terbutaline—Dyspnoea—Docetaxel—breast cancer	0.000223	0.00116	CcSEcCtD
Terbutaline—Somnolence—Docetaxel—breast cancer	0.000223	0.00116	CcSEcCtD
Terbutaline—Rash—Gemcitabine—breast cancer	0.000223	0.00116	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—breast cancer	0.000223	0.00116	CcSEcCtD
Terbutaline—Headache—Gemcitabine—breast cancer	0.000221	0.00115	CcSEcCtD
Terbutaline—Flushing—Epirubicin—breast cancer	0.000221	0.00115	CcSEcCtD
Terbutaline—Vomiting—Fluorouracil—breast cancer	0.000221	0.00115	CcSEcCtD
Terbutaline—Insomnia—Capecitabine—breast cancer	0.00022	0.00114	CcSEcCtD
Terbutaline—Rash—Fluorouracil—breast cancer	0.000219	0.00114	CcSEcCtD
Terbutaline—Dermatitis—Fluorouracil—breast cancer	0.000219	0.00114	CcSEcCtD
Terbutaline—Paraesthesia—Capecitabine—breast cancer	0.000218	0.00113	CcSEcCtD
Terbutaline—Headache—Fluorouracil—breast cancer	0.000218	0.00113	CcSEcCtD
Terbutaline—Dyspnoea—Capecitabine—breast cancer	0.000216	0.00113	CcSEcCtD
Terbutaline—Nausea—Irinotecan—breast cancer	0.000215	0.00112	CcSEcCtD
Terbutaline—Nausea—Mitoxantrone—breast cancer	0.000215	0.00112	CcSEcCtD
Terbutaline—Asthenia—Paclitaxel—breast cancer	0.000212	0.0011	CcSEcCtD
Terbutaline—Nausea—Gemcitabine—breast cancer	0.00021	0.00109	CcSEcCtD
Terbutaline—Nausea—Fluorouracil—breast cancer	0.000206	0.00107	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—breast cancer	0.000204	0.00106	CcSEcCtD
Terbutaline—Tension—Epirubicin—breast cancer	0.000203	0.00106	CcSEcCtD
Terbutaline—Nervousness—Epirubicin—breast cancer	0.000201	0.00105	CcSEcCtD
Terbutaline—Muscle spasms—Epirubicin—breast cancer	0.000199	0.00104	CcSEcCtD
Terbutaline—Dizziness—Paclitaxel—breast cancer	0.000196	0.00102	CcSEcCtD
Terbutaline—Chest pain—Methotrexate—breast cancer	0.000188	0.000981	CcSEcCtD
Terbutaline—Tension—Doxorubicin—breast cancer	0.000188	0.000979	CcSEcCtD
Terbutaline—Vomiting—Paclitaxel—breast cancer	0.000188	0.000979	CcSEcCtD
Terbutaline—Rash—Paclitaxel—breast cancer	0.000186	0.000971	CcSEcCtD
Terbutaline—Dermatitis—Paclitaxel—breast cancer	0.000186	0.00097	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—breast cancer	0.000186	0.000969	CcSEcCtD
Terbutaline—Headache—Paclitaxel—breast cancer	0.000185	0.000965	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—breast cancer	0.000184	0.000959	CcSEcCtD
Terbutaline—Palpitations—Epirubicin—breast cancer	0.000183	0.000953	CcSEcCtD
Terbutaline—Asthenia—Docetaxel—breast cancer	0.00018	0.000936	CcSEcCtD
Terbutaline—Chest pain—Epirubicin—breast cancer	0.000176	0.000918	CcSEcCtD
Terbutaline—Anxiety—Epirubicin—breast cancer	0.000176	0.000915	CcSEcCtD
Terbutaline—Nausea—Paclitaxel—breast cancer	0.000176	0.000915	CcSEcCtD
Terbutaline—Epinephrine—CYP3A4—breast cancer	0.000175	0.0384	CrCbGaD
Terbutaline—Hyperhidrosis—Methotrexate—breast cancer	0.000175	0.000909	CcSEcCtD
Terbutaline—Asthenia—Capecitabine—breast cancer	0.000174	0.000907	CcSEcCtD
Terbutaline—Dry mouth—Epirubicin—breast cancer	0.000172	0.000898	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—breast cancer	0.000169	0.000882	CcSEcCtD
Terbutaline—Dizziness—Docetaxel—breast cancer	0.000166	0.000863	CcSEcCtD
Terbutaline—Tachycardia—Epirubicin—breast cancer	0.000165	0.000859	CcSEcCtD
Terbutaline—Hyperhidrosis—Epirubicin—breast cancer	0.000163	0.000851	CcSEcCtD
Terbutaline—Insomnia—Methotrexate—breast cancer	0.000163	0.000851	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—breast cancer	0.000163	0.00085	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—breast cancer	0.000163	0.000847	CcSEcCtD
Terbutaline—Paraesthesia—Methotrexate—breast cancer	0.000162	0.000845	CcSEcCtD
Terbutaline—Dyspnoea—Methotrexate—breast cancer	0.000161	0.000839	CcSEcCtD
Terbutaline—Somnolence—Methotrexate—breast cancer	0.000161	0.000836	CcSEcCtD
Terbutaline—Dizziness—Capecitabine—breast cancer	0.00016	0.000836	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—breast cancer	0.00016	0.000831	CcSEcCtD
Terbutaline—Vomiting—Docetaxel—breast cancer	0.000159	0.00083	CcSEcCtD
Terbutaline—Rash—Docetaxel—breast cancer	0.000158	0.000823	CcSEcCtD
Terbutaline—Dermatitis—Docetaxel—breast cancer	0.000158	0.000822	CcSEcCtD
Terbutaline—Headache—Docetaxel—breast cancer	0.000157	0.000818	CcSEcCtD
Terbutaline—Vomiting—Capecitabine—breast cancer	0.000154	0.000803	CcSEcCtD
Terbutaline—Rash—Capecitabine—breast cancer	0.000153	0.000797	CcSEcCtD
Terbutaline—Insomnia—Epirubicin—breast cancer	0.000153	0.000796	CcSEcCtD
Terbutaline—Dermatitis—Capecitabine—breast cancer	0.000153	0.000796	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—breast cancer	0.000153	0.000795	CcSEcCtD
Terbutaline—Headache—Capecitabine—breast cancer	0.000152	0.000792	CcSEcCtD
Terbutaline—Paraesthesia—Epirubicin—breast cancer	0.000152	0.00079	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—breast cancer	0.000151	0.000787	CcSEcCtD
Terbutaline—Dyspnoea—Epirubicin—breast cancer	0.000151	0.000785	CcSEcCtD
Terbutaline—Somnolence—Epirubicin—breast cancer	0.00015	0.000783	CcSEcCtD
Terbutaline—Nausea—Docetaxel—breast cancer	0.000149	0.000775	CcSEcCtD
Terbutaline—Nausea—Capecitabine—breast cancer	0.000144	0.000751	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—breast cancer	0.000141	0.000737	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—breast cancer	0.00014	0.000731	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—breast cancer	0.000139	0.000726	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—breast cancer	0.000139	0.000724	CcSEcCtD
Terbutaline—Asthenia—Methotrexate—breast cancer	0.00013	0.000675	CcSEcCtD
Terbutaline—Asthenia—Epirubicin—breast cancer	0.000121	0.000632	CcSEcCtD
Terbutaline—Dizziness—Methotrexate—breast cancer	0.000119	0.000622	CcSEcCtD
Terbutaline—Vomiting—Methotrexate—breast cancer	0.000115	0.000598	CcSEcCtD
Terbutaline—Rash—Methotrexate—breast cancer	0.000114	0.000593	CcSEcCtD
Terbutaline—Dermatitis—Methotrexate—breast cancer	0.000114	0.000593	CcSEcCtD
Terbutaline—Headache—Methotrexate—breast cancer	0.000113	0.000589	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—breast cancer	0.000112	0.000584	CcSEcCtD
Terbutaline—Dizziness—Epirubicin—breast cancer	0.000112	0.000582	CcSEcCtD
Terbutaline—Vomiting—Epirubicin—breast cancer	0.000107	0.00056	CcSEcCtD
Terbutaline—Nausea—Methotrexate—breast cancer	0.000107	0.000559	CcSEcCtD
Terbutaline—Rash—Epirubicin—breast cancer	0.000107	0.000555	CcSEcCtD
Terbutaline—Dermatitis—Epirubicin—breast cancer	0.000107	0.000554	CcSEcCtD
Terbutaline—Headache—Epirubicin—breast cancer	0.000106	0.000551	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—breast cancer	0.000103	0.000539	CcSEcCtD
Terbutaline—Nausea—Epirubicin—breast cancer	0.0001	0.000523	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—breast cancer	9.95e-05	0.000518	CcSEcCtD
Terbutaline—Rash—Doxorubicin—breast cancer	9.86e-05	0.000514	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—breast cancer	9.85e-05	0.000513	CcSEcCtD
Terbutaline—Headache—Doxorubicin—breast cancer	9.8e-05	0.00051	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—breast cancer	9.29e-05	0.000484	CcSEcCtD
Terbutaline—BCHE—Metabolism—CA9—breast cancer	3.88e-05	0.000912	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.83e-05	0.000901	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL27—breast cancer	3.83e-05	0.000901	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL3—breast cancer	3.83e-05	0.000901	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INHBB—breast cancer	3.83e-05	0.000901	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDE2A—breast cancer	3.83e-05	0.000901	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.79e-05	0.000892	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDNRB—breast cancer	3.79e-05	0.000891	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA2—breast cancer	3.78e-05	0.000889	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX2—breast cancer	3.78e-05	0.000889	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX4—breast cancer	3.74e-05	0.000878	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SULT1A1—breast cancer	3.74e-05	0.000878	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BMPR2—breast cancer	3.66e-05	0.000859	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DLL4—breast cancer	3.66e-05	0.000859	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—IDH1—breast cancer	3.65e-05	0.000858	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA1—breast cancer	3.65e-05	0.000858	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NAT2—breast cancer	3.61e-05	0.000848	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGTR2—breast cancer	3.59e-05	0.000845	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL2—breast cancer	3.59e-05	0.000845	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTHLH—breast cancer	3.55e-05	0.000835	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDH5—breast cancer	3.5e-05	0.000824	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CALCA—breast cancer	3.45e-05	0.00081	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDNRB—breast cancer	3.44e-05	0.000809	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SFRP2—breast cancer	3.44e-05	0.000808	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRLR—breast cancer	3.37e-05	0.000793	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL12—breast cancer	3.37e-05	0.000791	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCR4—breast cancer	3.37e-05	0.000791	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.26e-05	0.000767	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VCP—breast cancer	3.26e-05	0.000766	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GLI2—breast cancer	3.26e-05	0.000766	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	3.24e-05	0.000762	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEPR—breast cancer	3.21e-05	0.000753	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MED12—breast cancer	3.16e-05	0.000744	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—DPYD—breast cancer	3.16e-05	0.000744	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CALCA—breast cancer	3.13e-05	0.000735	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALDOA—breast cancer	3.11e-05	0.000732	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCR4—breast cancer	3.06e-05	0.000718	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL12—breast cancer	3.06e-05	0.000718	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGTR1—breast cancer	3.04e-05	0.000715	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA3—breast cancer	3.02e-05	0.000711	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A2—breast cancer	3e-05	0.000706	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ARHGDIA—breast cancer	2.98e-05	0.0007	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.97e-05	0.000698	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HRAS—breast cancer	2.96e-05	0.000697	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTR—breast cancer	2.94e-05	0.000691	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CPT1A—breast cancer	2.94e-05	0.000691	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG2—breast cancer	2.94e-05	0.000691	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP1—breast cancer	2.94e-05	0.000691	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FST—breast cancer	2.9e-05	0.000682	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HPGDS—breast cancer	2.88e-05	0.000678	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HEY2—breast cancer	2.87e-05	0.000674	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HBA1—breast cancer	2.87e-05	0.000674	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LEP—breast cancer	2.84e-05	0.000669	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RPS6KB2—breast cancer	2.83e-05	0.000666	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RGS2—breast cancer	2.8e-05	0.000658	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACHE—breast cancer	2.8e-05	0.000658	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTT1—breast cancer	2.8e-05	0.000658	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL20—breast cancer	2.77e-05	0.000651	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGTR1—breast cancer	2.76e-05	0.00065	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ITPR1—breast cancer	2.73e-05	0.000642	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPAR1—breast cancer	2.68e-05	0.000631	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TLE3—breast cancer	2.68e-05	0.000631	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HEY1—breast cancer	2.66e-05	0.000624	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP17A1—breast cancer	2.65e-05	0.000622	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS1—breast cancer	2.62e-05	0.000616	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ENO1—breast cancer	2.62e-05	0.000616	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.61e-05	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DLL1—breast cancer	2.6e-05	0.000612	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.58e-05	0.000606	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2D6—breast cancer	2.57e-05	0.000604	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIST1H2BC—breast cancer	2.56e-05	0.000601	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIST1H2BK—breast cancer	2.56e-05	0.000601	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDE4D—breast cancer	2.53e-05	0.000595	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRB7—breast cancer	2.53e-05	0.000595	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA2—breast cancer	2.52e-05	0.000593	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CSF2—breast cancer	2.52e-05	0.000593	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TAB2—breast cancer	2.49e-05	0.000585	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ITPR1—breast cancer	2.48e-05	0.000583	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CNR2—breast cancer	2.47e-05	0.00058	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—breast cancer	2.47e-05	0.00058	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MMP3—breast cancer	2.46e-05	0.000579	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—FASN—breast cancer	2.45e-05	0.000575	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DKK1—breast cancer	2.41e-05	0.000566	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC5A5—breast cancer	2.41e-05	0.000566	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFC—breast cancer	2.39e-05	0.000562	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAG2—breast cancer	2.36e-05	0.000554	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—breast cancer	2.35e-05	0.000553	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A1—breast cancer	2.33e-05	0.000547	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NQO1—breast cancer	2.33e-05	0.000547	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—WNT1—breast cancer	2.32e-05	0.000546	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PLA2G4A—breast cancer	2.32e-05	0.000544	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CSF2—breast cancer	2.29e-05	0.000538	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.28e-05	0.000535	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—breast cancer	2.28e-05	0.000535	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HRAS—breast cancer	2.27e-05	0.000534	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP3A4—breast cancer	2.27e-05	0.000533	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.26e-05	0.00053	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1B1—breast cancer	2.23e-05	0.000524	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH4—breast cancer	2.2e-05	0.000517	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GZMB—breast cancer	2.19e-05	0.000514	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSP90AA1—breast cancer	2.19e-05	0.000514	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA1—breast cancer	2.13e-05	0.0005	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGTR2—breast cancer	2.12e-05	0.000499	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL2—breast cancer	2.12e-05	0.000499	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTHLH—breast cancer	2.1e-05	0.000493	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BMP2—breast cancer	2.1e-05	0.000493	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—STK11—breast cancer	2.1e-05	0.000493	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP19A1—breast cancer	2.1e-05	0.000493	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDNRB—breast cancer	2.03e-05	0.000478	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PGR—breast cancer	2.01e-05	0.000473	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—THBS1—breast cancer	2e-05	0.000471	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.97e-05	0.000462	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—COMT—breast cancer	1.95e-05	0.000458	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTP1—breast cancer	1.94e-05	0.000456	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMOX1—breast cancer	1.91e-05	0.00045	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FLT1—breast cancer	1.91e-05	0.000449	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ITPR1—breast cancer	1.91e-05	0.000449	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF3—breast cancer	1.9e-05	0.000447	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SQSTM1—breast cancer	1.9e-05	0.000447	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	1.89e-05	0.000445	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—breast cancer	1.89e-05	0.000444	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAG1—breast cancer	1.88e-05	0.000442	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH3—breast cancer	1.87e-05	0.00044	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PARP1—breast cancer	1.87e-05	0.00044	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CALCA—breast cancer	1.85e-05	0.000434	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCB1—breast cancer	1.84e-05	0.000431	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RPS6—breast cancer	1.83e-05	0.000429	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF4—breast cancer	1.81e-05	0.000426	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR4—breast cancer	1.81e-05	0.000424	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL12—breast cancer	1.81e-05	0.000424	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TYMS—breast cancer	1.8e-05	0.000424	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLA2G4A—breast cancer	1.78e-05	0.000419	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOR1—breast cancer	1.78e-05	0.000419	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—breast cancer	1.78e-05	0.000419	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PAK1—breast cancer	1.77e-05	0.000416	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CTNNB1—breast cancer	1.74e-05	0.00041	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.74e-05	0.000409	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.73e-05	0.000407	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.72e-05	0.000404	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX1—breast cancer	1.71e-05	0.000401	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1A1—breast cancer	1.69e-05	0.000397	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.68e-05	0.000394	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.68e-05	0.000394	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ERCC2—breast cancer	1.68e-05	0.000394	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.66e-05	0.000391	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRL—breast cancer	1.63e-05	0.000384	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGTR1—breast cancer	1.63e-05	0.000384	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STK11—breast cancer	1.61e-05	0.000378	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADAM10—breast cancer	1.61e-05	0.000378	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLG—breast cancer	1.59e-05	0.000374	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—breast cancer	1.58e-05	0.00037	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT2—breast cancer	1.57e-05	0.00037	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF10—breast cancer	1.57e-05	0.000368	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	1.51e-05	0.000355	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFA—breast cancer	1.51e-05	0.000355	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFBR2—breast cancer	1.49e-05	0.00035	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ITPR1—breast cancer	1.47e-05	0.000344	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB4—breast cancer	1.46e-05	0.000342	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT5A—breast cancer	1.46e-05	0.000342	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP3—breast cancer	1.46e-05	0.000342	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CAV1—breast cancer	1.45e-05	0.000341	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	1.45e-05	0.000341	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SMAD4—breast cancer	1.41e-05	0.000331	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1R—breast cancer	1.4e-05	0.000329	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	1.39e-05	0.000328	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.39e-05	0.000326	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HES1—breast cancer	1.38e-05	0.000323	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	1.37e-05	0.000322	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NCOR1—breast cancer	1.37e-05	0.000322	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CSF2—breast cancer	1.35e-05	0.000318	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF1—breast cancer	1.35e-05	0.000318	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RAF1—breast cancer	1.35e-05	0.000317	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRG1—breast cancer	1.34e-05	0.000316	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—H2AFX—breast cancer	1.33e-05	0.000313	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2—breast cancer	1.33e-05	0.000313	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—E2F1—breast cancer	1.32e-05	0.000311	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—breast cancer	1.32e-05	0.000311	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	1.32e-05	0.00031	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SPP1—breast cancer	1.27e-05	0.000299	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—breast cancer	1.27e-05	0.000298	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB3—breast cancer	1.26e-05	0.000296	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR2—breast cancer	1.26e-05	0.000295	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2—breast cancer	1.21e-05	0.000284	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—breast cancer	1.21e-05	0.000283	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR1—breast cancer	1.17e-05	0.000275	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—breast cancer	1.16e-05	0.000273	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—breast cancer	1.15e-05	0.000271	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—breast cancer	1.15e-05	0.00027	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEP—breast cancer	1.13e-05	0.000265	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CAV1—breast cancer	1.12e-05	0.000262	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KDR—breast cancer	1.1e-05	0.000259	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NOS3—breast cancer	1.1e-05	0.000258	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ESR1—breast cancer	1.07e-05	0.000253	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FN1—breast cancer	1.06e-05	0.00025	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKBIA—breast cancer	1.05e-05	0.000247	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH1—breast cancer	1.04e-05	0.000244	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APC—breast cancer	1.02e-05	0.000239	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.02e-05	0.000239	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KIT—breast cancer	1.02e-05	0.000239	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—breast cancer	1.01e-05	0.000238	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—breast cancer	1e-05	0.000236	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGF—breast cancer	1e-05	0.000236	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK3—breast cancer	9.73e-06	0.000229	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BRAF—breast cancer	9.55e-06	0.000224	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—breast cancer	9.3e-06	0.000219	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT2—breast cancer	9.3e-06	0.000218	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—breast cancer	9.26e-06	0.000218	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—breast cancer	8.93e-06	0.00021	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	8.85e-06	0.000208	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SERPINE1—breast cancer	8.83e-06	0.000208	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—breast cancer	8.76e-06	0.000206	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—breast cancer	8.74e-06	0.000206	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOS3—breast cancer	8.43e-06	0.000198	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	8.03e-06	0.000189	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MDM2—breast cancer	8e-06	0.000188	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RAF1—breast cancer	7.97e-06	0.000187	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RELA—breast cancer	7.94e-06	0.000187	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ERBB2—breast cancer	7.89e-06	0.000185	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTOR—breast cancer	7.78e-06	0.000183	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—breast cancer	7.78e-06	0.000183	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—breast cancer	7.48e-06	0.000176	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRAS—breast cancer	7.43e-06	0.000175	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1B—breast cancer	7.31e-06	0.000172	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—breast cancer	7.23e-06	0.00017	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—breast cancer	7.16e-06	0.000168	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2—breast cancer	7.15e-06	0.000168	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—breast cancer	7.11e-06	0.000167	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—breast cancer	6.97e-06	0.000164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JUN—breast cancer	6.95e-06	0.000163	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTNNB1—breast cancer	6.9e-06	0.000162	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—breast cancer	6.77e-06	0.000159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1A—breast cancer	6.74e-06	0.000158	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—breast cancer	6.73e-06	0.000158	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK8—breast cancer	6.58e-06	0.000155	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—breast cancer	6.56e-06	0.000154	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—breast cancer	6.24e-06	0.000147	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—breast cancer	6.18e-06	0.000145	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—breast cancer	6.08e-06	0.000143	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—breast cancer	6.02e-06	0.000141	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK3—breast cancer	5.75e-06	0.000135	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—breast cancer	5.59e-06	0.000131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—breast cancer	5.58e-06	0.000131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—breast cancer	5.47e-06	0.000129	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—breast cancer	5.17e-06	0.000121	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—breast cancer	5.05e-06	0.000119	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—breast cancer	4.75e-06	0.000112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—breast cancer	4.59e-06	0.000108	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRAS—breast cancer	4.39e-06	0.000103	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—breast cancer	4.2e-06	9.88e-05	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—breast cancer	3.88e-06	9.11e-05	CbGpPWpGaD
